MarketsThis New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround StoryMarch 22, 2026
MarketsThis $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug LaunchMarch 22, 2026
MarketsOracle Stock Has Lost More Than Half Its Value in 6 Months. It May Finally Be Time to Buy.March 21, 2026
